Predicting real-world effectiveness using overall survival and progression-free survival-based clinical trial efficacy measures

被引:0
|
作者
Shafrin, Jason
Hou, Ningqi
Brookmeyer, Ron
Peneva, Desi
Vine, Seanna
Park, Jinhee
Zhang, Jie
Figlin, Robert A.
Lakdawalla, Darius N.
机构
[1] Precis Hlth Econ, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[5] Univ Southern Calif, Los Angeles, CA USA
关键词
D O I
10.1200/JCO.2016.34.15_suppl.6564
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6564
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework
    Lakdawalla, Darius N.
    Shafrin, Jason
    Hou, Ningqi
    Peneva, Desi
    Vine, Seanna
    Park, Jinhee
    Zhang, Jie
    Brookmeyer, Ron
    Figlin, Robert A.
    VALUE IN HEALTH, 2017, 20 (07) : 866 - 875
  • [2] A proper statistical inference framework to compare clinical trial and real-world progression-free survival data
    Zhu, Jian
    Tang, Rui
    STATISTICS IN MEDICINE, 2022, 41 (29) : 5738 - 5752
  • [3] OVERALL SURVIVAL VERSUS PROGRESSION-FREE SURVIVAL IN ONCOLOGY CLINICAL TRIALS
    Aissaoui, A.
    Bin Sawad, A.
    Turkistani, F.
    Aissaoui, N.
    VALUE IN HEALTH, 2016, 19 (07) : A717 - A717
  • [4] Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis
    Han, Weiming
    Wang, Lan
    Li, Chen
    Chen, Junqiang
    Zhang, Wencheng
    Wang, Xin
    Pang, Qingsong
    Zhao, Yidian
    Sun, Xinchen
    Zhang, Kaixian
    Li, Gaofeng
    Li, Ling
    Qiao, Xueying
    Liu, Miaoling
    Wang, Yadi
    Deng, Lei
    Wang, Wenqing
    Bi, Nan
    Zhang, Tao
    Deng, Wei
    Ni, Wenjie
    Chang, Xiao
    Zhou, Zongmei
    Liang, Jun
    Feng, Qinfu
    Wang, Lvhua
    Chen, Dongfu
    Lv, Jima
    Zhu, Shuchai
    Han, Chun
    Xiao, Zefen
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [5] Real-World Progression-Free Survival as an Endpoint in Lung Cancer: Replicating Atezolizumab and Docetaxel Arms of the OAK Trial Using Real-World Data
    Mhatre, Shivani K.
    Machado, Robson J. M.
    Ton, Thanh G. N.
    Trinh, Huong
    Mazieres, Julien
    Rittmeyer, Achim
    Bretscher, Michael T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (06) : 1313 - 1322
  • [6] Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting
    Kassik, Marie-Theres
    Vordermark, Dirk
    Kornhuber, Christine
    Medenwald, Daniel
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [7] Factors associated with overall survival, progression-free survival and toxicity in patients with small cell lung cancer and thoracic irradiation in a clinical real-world setting
    Marie-Theres Kassik
    Dirk Vordermark
    Christine Kornhuber
    Daniel Medenwald
    Radiation Oncology, 18
  • [8] Replication of Overall Survival, Progression-Free Survival, and Overall Response in Chemotherapy Arms of Non-Small Cell Lung Cancer Trials Using Real-World Data
    Ton, Thanh G. N.
    Pal, Navdeep
    Trinh, Huong
    Mahrus, Sami
    Bretscher, Michael T.
    Machado, Robson J. M.
    Sadetsky, Natalia
    Chaudhary, Nayan
    Lu, Michael W.
    Riely, Gregory J.
    CLINICAL CANCER RESEARCH, 2022, 28 (13) : 2844 - 2853
  • [9] Predicting Overall Survival and Progression-Free Survival Using Tumor Dynamics in Advanced Breast Cancer Patients
    Hyeong-Seok Lim
    Wan Sun
    Kourosh Parivar
    Diane Wang
    The AAPS Journal, 21
  • [10] Predicting Overall Survival and Progression-Free Survival Using Tumor Dynamics in Advanced Breast Cancer Patients
    Lim, Hyeong-Seok
    Sun, Wan
    Parivar, Kourosh
    Wang, Diane
    AAPS JOURNAL, 2019, 21 (02):